This inventor holds 12 USPTO granted patents and 4 published patent applications, plus 2 CIPO patents. Top assignees: Washington University, Other. Active years: 1995-2020.
Company Filing History:
11 out of 1,375 
1 out of 834,350 Years Active: 1995-2020
Title: Alan Pestronk: Innovator in Neuropathology
Introduction
Alan Pestronk is a distinguished inventor based in St. Louis, MO (US). He has made significant contributions to the field of neuropathology, holding a total of 12 patents. His work focuses on understanding and diagnosing conditions related to the TDP-43 proteinopathies.
Latest Patents
Among his latest patents is a groundbreaking invention titled "Sequences associated with TDP-43 proteinopathies and methods of using the same." This invention provides nucleic acids and peptides, along with methods for using them to identify subjects at risk for TDP-43 proteinopathy. Another notable patent is "Antibodies to disulfated heparin disaccharide in the diagnosis of neuropathy." This patent discloses methods that aid in diagnosing certain neuropathies by assessing the titer of antibodies to a disulfated heparin disaccharide in test samples from subjects. Additionally, the invention includes apparatus and kits that can be utilized in these diagnostic methods.
Career Highlights
Alan Pestronk has had a notable career, working at Washington University, where he has contributed to various research initiatives. His innovative work has led to advancements in the understanding of neuropathological conditions.
Collaborations
Throughout his career, Alan has collaborated with esteemed colleagues, including Michael A Gitcho and Alison M Goate. These collaborations have further enriched his research and contributions to the field.
Conclusion
Alan Pestronk's innovative work in neuropathology has led to significant advancements in the diagnosis and understanding of TDP-43 proteinopathies. His contributions continue to impact the field positively.